Edwards Lifesciences Corporation

NYSE (USD): Edwards Lifesciences Corporation (EW)

Last Price

74.53

Today's Change

+0.725 (0.98%)

Day's Change

73.01 - 74.79

Trading Volume

828,421

Overview

Market Cap

43 Billion

Shares Outstanding

589 Million

Avg Volume

5,873,412

Avg Price (50 Days)

68.95

Avg Price (200 Days)

78.76

PE Ratio

28.80

EPS

2.59

Earnings Announcement

04-Feb-2025

Previous Close

73.81

Open

73.27

Day's Range

73.01 - 74.79

Year Range

58.93 - 96.12

Trading Volume

837,530

Price Change Highlight

1 Day Change

1.05%

5 Day Change

2.58%

1 Month Change

13.33%

3 Month Change

9.47%

6 Month Change

-15.02%

Ytd Change

-1.30%

1 Year Change

3.33%

3 Year Change

-38.23%

5 Year Change

-3.01%

10 Year Change

247.26%

Max Change

5324.36%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment